Claude Nicaise, Director at Sarepta Therapeutics, Inc. (SRPT), sold 4,982 shares at $99.64 ($496K) on 2025-03-12, disclosed to the SEC on 2025-03-13.
Seasonal sale ($496k) by Director — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.64 | 2,491 | $248K | 50.0% |
| 2 | $99.64 | 2,491 | $248K | 50.0% |
| Total | $99.64 avg | 4,982 | $496K | 100% |